Updated: May 15, 2023
JYNNEOS is a 2-dose vaccine that is given by injection. No additional booster doses are recommended after you have received 2 doses.
- Subcutaneous injection. This means that the vaccine is given beneath the skin in the upper arm. This method is used for people who are younger than age 18 and people of any age who have had keloid scars as well as in patients who prefer subcutaneous injections. A keloid scar is a thick, raised scar that can form after skin damage, such as a cut, piercing, or surgery.
- Intradermal injection. This means that the vaccine is given between the layers of skin. This method is used for most people ages 18 years and older. People getting the vaccine this way may choose one of 3 places to get this injection: on the forearm (inside of the arm between the wrist and the elbow); on the upper back below the shoulder blade; at the deltoid (shoulder muscle). You can see pictures of people getting the vaccines on the forearm, upper back, or shoulder. You can see pictures of people getting the vaccines on the forearm, upper back, or shoulder.
Currently, the intradermal method is being offered for most people ages 18 and older. However, if you have a concern for keloid scarring or you prefer getting the vaccine subcutaneously, you can receive it that way. Be sure to tell the vaccine provider your preference.
WHO SHOULD GET VACCINATED
Updated: December 22, 2022
The Los Angeles County Department of Public Health recommends that those who may be at risk for, or seek additional protection from mpox infection, be vaccinated against mpox. Anyone who requests vaccination can receive it without having to disclose information on personal risk.
The following groups remain at- risk for mpox and are encouraged to get vaccinated to protect against mpox infection and severe disease:
- Any man or transgender person who has sex with men or transgender persons
- Persons of any gender or sexual orientation who engage in commercial and/or transactional sex or have sex in association with a large public event
- Persons living with HIV, especially persons with uncontrolled or advanced HIV disease
- Persons who had skin-to-skin or intimate contact with someone with suspected or confirmed mpox, including those who have not yet been confirmed by Public Health
- Sexual partners of people in any of the above groups
- People who anticipate being in any of the above groups
Public Health is also directly communicating with people who have had high- or intermediate-risk contact with someone with mpox (as defined by CDC and confirmed by Public Health) to provide vaccination.
Consent for Minors
- At DPH vaccination sites (e.g., DPH Centers and DPH Points of Dispensing), minors between the ages of 12-17 may consent to receiving the vaccine. Please refer to the DPH justification for more information. If you are younger than 18 and plan to receive the vaccine at a non-DPH site, please contact the vaccine provider to learn about their requirements for parental consent.
- Children under the age of 12 must be accompanied by their parent, legal guardian, or a responsible adult. If the child is accompanied by a responsible adult, the consent form must name the responsible person and be signed by the parent or legal guardian.
Residents who received their first dose of vaccine over 28 days ago SHOULD receive their second dose. Persons who signed up for their first dose on this website and are due for their second dose may go to a Public vaccinating site with their vaccination record or they can visit myturn.ca.gov to find other second dose vaccinating sites near them. Persons who received their first dose with their health care provider should contact their health care provider to schedule an appointment for a second dose.
Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. Document functionality may be reduced if you are using an earlier version (4.x or less). Get the latest version of Adobe Acrobat.
Public Health has made reasonable efforts to provide accurate translation. However, no computerized translation is perfect and is not intended to replace traditional translation methods. If questions arise concerning the accuracy of the information, please refer to the English edition of the website, which is the official version.